Hybridize's mission is to help patients overcome untreated kidney diseases. We do this by developing RNA-based therapies.
Currently, we are nearing Phase 1 clinical trials (together with our partner AiCuris Anti-Infectives) for our therapy against BK-virus.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Leiden, South Holland, Nl
- Phone
- +31-617524713
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- hybridizetherapeutics.com
- HQ
- Leiden, South Holland
Hybridize Therapeutics Questions
Hybridize Therapeutics's helpline number is +31-617524713
Hybridize Therapeutics's website is hybridizetherapeutics.com
Hybridize Therapeutics's LinkedIn profile is https://nl.linkedin.com/company/hybridize
Hybridize Therapeutics has
4 employees.
View email and phone details for 4
employees at Hybridize Therapeutics.
Hybridize Therapeutics's industry is
Biotechnology Research
Hybridize Therapeutics's top competitors are
M3 Pharma Consultancy,
Vitroscan,
Alesta Therapeutics,
3d-Pharmxchange,
Leyden Labs,
Agomab,
Thuja Capital,
Proqr Therapeutics,
Imuno Therapeutics,
Rapidemic.
Hybridize Therapeutics's support email address is info@hybridizetherapeutics.com
Hybridize Therapeutics's categories are Biotechnology Research
Hybridize Therapeutics's founding year is 2019
